Research Topics
| Nicole MittmannSummaryAffiliation: Sunnybrook and Women's College Health Sciences Centre Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Evaluation of the extent of under-reporting of serious adverse drug reactions: the case of toxic epidermal necrolysisNicole Mittmann
Department of Pharmacology, Division of Clinical Pharmacology, University of Toronto, Toronto, Ontario, Canada
Drug Saf 27:477-87. 2004..In Canada, reports are made to the Canadian Adverse Drug Reaction Monitoring Program (CADRMP)...
Once daily dosing improves adherence to antiretroviral therapyJanet Raboud
Division of Infectious Disease, University Health Network, Toronto, ON, Canada
AIDS Behav 15:1397-409. 2011..Other independent correlates of suboptimal adherence were younger age, lower positive social interaction and increased frequency of consuming > 6 alcoholic drinks on one occasion...
The economic burden of patient safety targets in acute care: a systematic reviewNicole Mittmann
Health Outcomes and Pharmaco Economics HOPE Research Centre, Division of Clinical Pharmacology, Toronto, ON, Canada
Drug Healthc Patient Saf 4:141-65. 2012..Our objective was to determine the quality of literature in costing of the economic burden of patient safety...- Evaluation of direct medical costs of hospitalization for febrile neutropeniaNina Lathia
Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada
Cancer 116:742-8. 2010..As cancer rates continue to increase, the number of patients suffering from FN will also increase, making it important to quantify the costs of treating this condition accurately and comprehensively... - Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trialNicole Mittmann
Health Outcomes and Pharmacoeconomics Research Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
J Natl Cancer Inst 101:1182-92. 2009..17 study who received cetuximab plus best supportive care (N = 283) or best supportive care alone (N = 274)... - Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series studyNicole Mittmann
HOPE Research Centre, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
Am J Clin Dermatol 13:49-54. 2012..Accessibility to a cohort of individuals with HIV with known drug exposure (including drug, dose, and time of exposure) and collection of adverse-event information may provide an opportunity to determine an incidence rate of SJS and TEN... - Work-related lost productivity and its economic impact on Canadian patients with moderate to severe psoriasisBrian Chan
Health Outcomes and PharmacoEconomics HOPE Research Centre, Division of Clinical Pharmacology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada
J Cutan Med Surg 13:192-7. 2009..Psoriasis impacts many different areas of a patient's life, including work productivity. There is no information regarding lost productivity owing to psoriasis in a Canadian population... - Effect of intravenous immunoglobulin on prednisone dose in patients with pemphigus vulgarisNicole Mittmann
Division of Clinical Pharmacology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Canada
J Cutan Med Surg 10:222-7. 2006..Patients unresponsive to high-dose systemic corticosteroids and conventional immunosuppressants may respond to intravenous immunoglobulin (IVIG)... - Eliciting patients' preferences for outpatient treatment of febrile neutropenia: a discrete choice experimentNina Lathia
Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada
Support Care Cancer 21:245-51. 2013..The purpose of this study was to elicit non-Hodgkin lymphoma patients' preferences on attributes related to outpatient treatment of FN... - Guidelines for health technologies: specific guidance for oncology products in CanadaNicole Mittmann
Committee on Economic Analysis formerly Working Group on Economic Analysis, NCIC Clinical Trials Group, Kingston, ON, Canada
Value Health 15:580-5. 2012.... - Screening and prevention of venous thromboembolism in critically ill patients: a decision analysis and economic evaluationSachin Sud
Trillium Health Center, Mississauga, Ontario, Canada
Am J Respir Crit Care Med 184:1289-98. 2011..Venous thromboembolism is difficult to diagnose in critically ill patients and may increase morbidity and mortality... - Measurement of utility in nonmelanoma skin cancerWilliam Lear
Division of Dermatology, Skin Surgery Centre, Women s College Hospital, Toronto, Ontario, Canada
J Cutan Med Surg 12:102-6. 2008..Past studies have used multiattribute methods to assess quality of life. In contrast, the present study uses health utility methods, which rate a patient's quality of life from 0 to 1, with 1 representing perfect health... - Impact of impairment and secondary health conditions on health preference among Canadians with chronic spinal cord injuryCatharine Craven
Lyndhurst Centre, Toronto Rehabilitation Institute, University Health Network, Toronto, Ontario, Canada
J Spinal Cord Med 35:361-70. 2012..CONTEXT/OBJECTIVES: To describe the relationships between secondary health conditions and health preference in a cohort of adults with chronic spinal cord injury (SCI)... - Evaluation of the cost-effectiveness of electrical stimulation therapy for pressure ulcers in spinal cord injuryNicole Mittmann
Health Outcomes and Pharmacoeconomics Research Centre, Division of Clinical Pharmacology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
Arch Phys Med Rehabil 92:866-72. 2011.... - The direct medical costs associated with suspected heparin-induced thrombocytopeniaNatasha Nanwa
Graduate Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada
Pharmacoeconomics 29:511-20. 2011..Although the management of suspected HIT is resource intensive, few studies have assessed the cost burden associated with HIT, and none have assessed the costs of suspected HIT... - Cost of medications in patients admitted to a burn centerPatricia Cornish
Department of Pharmacy, Sunnybrook and Women s College Health Sciences Centre, Toronto, Ontario, Canada
Am J Clin Dermatol 4:861-7. 2003..No studies to date have examined the overall drug utilization and costs of medications used in the treatment of burn patients... - Derivation of utility values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 questionnaire values in lung cancerRaymond W Jang
Division of Medical Oncology, Princess Margaret Hospital University Health Network, Toronto, Ontario, Canada
J Thorac Oncol 5:1953-7. 2010.... - A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilitiesNicole Mittmann
HOPE Research Centre, Division of Clinical Pharmacology, Sunnybrook Health Sciences Centre, Toronto, Canada
Can J Clin Pharmacol 16:e171-7. 2009..Pharmacy and Therapeutics (P&T) committees have traditionally evaluated and developed policies for the clinical use of medications and for ensuring safe and effective drug use and administration... - Comparative economic analyses of patient safety improvement strategies in acute care: a systematic reviewEdward Etchells
University of Toronto Centre for Patient Safety, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
BMJ Qual Saf 21:448-56. 2012..The objective was to systematically review comparative economic analyses of patient safety improvements in the acute care setting... - HIV/hepatitis C virus and HIV/hepatitis B virus coinfections protect against antiretroviral-related hyperlipidaemiaC Diong
University Health Network, Toronto, Ontario, Canada
HIV Med 12:403-11. 2011..Hyperlipidaemia is a recognized complication of HIV antiretroviral therapy. The interactions among HIV, viral hepatitis, antiretroviral therapies and lipids are poorly understood... - Economic analysis of NCIC CTG JBR.10: a randomized trial of adjuvant vinorelbine plus cisplatin compared with observation in early stage non-small-cell lung cancer--a report of the Working Group on Economic Analysis, and the Lung Disease Site Group, NatioRaymond Ng
Department of Hematology and Medical Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada
J Clin Oncol 25:2256-61. 2007..This cost-effectiveness analysis of adjuvant chemotherapy from the perspective of Canada's public health care system was undertaken based on the JBR.10 study population... - Mastery and coping moderate the negative effect of acute and chronic stressors on mental health-related quality of life in HIVKatherine Gibson
The Ontario HIV Treatment Network, Toronto, Canada
AIDS Patient Care STDS 25:371-81. 2011..They also highlight that it is important for clinicians to be mindful of the impact of life stressors on the health of patients living with HIV... - Cost-effectiveness of switching to exemestane versus continued tamoxifen as adjuvant therapy for postmenopausal women with primary breast cancerNancy A Risebrough
HOPE Research Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Cancer 110:499-508. 2007.... - Cost comparisons of managing complex facial basal cell carcinoma: Canadian studyWilliam Lear
Division of Dermatology, University of Toronto, Women s College Hospital, Toronto, ON
J Cutan Med Surg 12:82-7. 2008..Although expensive to the health care system, no Canadian studies have reported the costs involved in management. This study calculated the costs of managing high-risk BCCs using radiotherapy (RT) and Mohs micrographic surgery (MMS)... - The impact of follicular (FL) and other indolent non-Hodgkin's lymphomas (NHL) on work productivity-a preliminary analysisMatthew C Cheung
Hematology Oncology, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario, Canada
Psychooncology 18:554-9. 2009..Although much is known about the efficacy, toxicity, and direct costs of treatment for follicular lymphoma (FL), there is no data assessing the impact of this diagnosis on the work productivity of affected individuals... - Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndromeNicole Mittmann
Division of Clinical Pharmacology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Am J Clin Dermatol 7:359-68. 2006..4 +/- 1.0 days in SJS patients. The clinical experience of IVIg use in TEN and SJS patients was positive in most cases. However, more studies need to be conducted to confirm the benefit of IVIg use in patients with TEN or SJS... - Cost effectiveness of budesonide/formoterol added to tiotropium bromide versus placebo added to tiotropium bromide in patients with chronic obstructive pulmonary disease: Australian, Canadian and Swedish healthcare perspectivesNicole Mittmann
Health Outcomes and PharmacoEconomic HOPE Research Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
Pharmacoeconomics 29:403-14. 2011..International guidelines recommend the addition of an inhaled corticosteroid (ICS) to a long-acting β₂-adrenoceptor agonist (LABA) for patients with severe to very severe COPD and a history of exacerbations... - Urgent care costs of uncontrolled asthma in Canada, 2004Soo Jin Seung
Sunnybrook and Women s College Health Sciences Centre, Toronto, Canada
Can Respir J 12:435-6. 2005..Improved control of asthma could decrease these costs... - Erectile dysfunction in spinal cord injury: a cost-utility analysisNicole Mittmann
Department of Pharmacology, Sunnybrook and Women s College Health Sciences Centre, University of Toronto, 2075 Bayview Avenue E240, Toronto, Ontario M4N 3M5, Canada
J Rehabil Med 37:358-64. 2005..However, physical impairments and accessibility may preclude patient self-utilization of non-oral treatments...